Improving Patient Involvement in Medicines Research and Development:: A Practical Roadmap.

Area of Science:

• Pharmacology and Pharmaceutical Sciences
• Health Services Research
• Patient and Public Involvement (PPI)

Background:

• Growing recognition of patient involvement (PI) in medicines research and development (R&D) among health stakeholders.
• Current PI initiatives lack consistent structure and formal documentation, hindering knowledge sharing and systematic implementation.
• Need for a standardized approach to effectively integrate patient perspectives throughout the R&D process.

Purpose of the Study:

• To present a practical roadmap for patient involvement (PI) in medicines R&D.
• To identify specific opportunities for PI across the four key stages of the medicines R&D lifecycle.
• To provide a tool for facilitating and refining PI in drug development.

Main Methods:

• Synthesis of outcomes from multistakeholder discussions held between 2013 and 2016.
• Development of a roadmap detailing PI opportunities within the medicines R&D lifecycle.
• Inclusion of concrete examples to illustrate practical application of PI.

Main Results:

• A structured roadmap outlining actionable steps for patient involvement in medicines R&D.
• Identification of key opportunities for PI at each stage of the R&D process.
• Provision of practical examples demonstrating successful PI implementation.

Conclusions:

• The developed roadmap serves as a valuable tool to enhance patient involvement in medicines R&D.
• Encourages the systematic implementation and further refinement of PI strategies.
• Aims to improve the efficiency and effectiveness of drug development through structured patient engagement.